Padcev-Keytruda will now join Bristol Myers Squibb’s Opdivo in the list of bladder cancer drugs available on the NHS.

Celldex will stop development of barzolvolimab in eosinophilic esophagitis, but it will continue progressing the drug in ...

The upcoming Clinical Trials in Rare Diseases conference will cover the most concerning challenges in rare disease research.

Precision immunology company Scipher Medicine has introduced the ClinicalTrialRank.com AI platform to the public.

The long-term data supports the drug’s progression into the HEALEY ALS Platform trial, with NUZ-001 dosing set to commence in Q4 2025. This will only begin, however, if the US Food and Drug ...

A501, which was placed on hold due to a patient death, will now resume with a reduced dose and altered regimen.

UK-based Monument Therapeutics has joined forces with the Foundation for the National Institutes of Health (FNIH), US, to ...

The FDA has announced it will no longer accept clinical trials that involve sending US patients cells from US to China for ...

Degrees Pharmaceuticals has entered into a clinical study agreement with the Icahn School of Medicine at Mount Sinai in the ...

MTPA's oral therapy Radicava (edaravone) has shown decreased functional decline and improved survival in long-term ALS trials ...

A recently published study provides an incentive to explore what specific aspects of vegetarianism are protective.

Anocca has secured approximately Skr440m (around $46m) to primarily support the early-stage clinical trials of VIDAR-1.